Ascendis Pharma A (ASND) EBITDA Margin (QoQ) (2014 - 2026)
Powered by 
Analysis
Ascendis Pharma A (ASND) EBITDA Margin (QoQ) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Ascendis Pharma A | 16.39 Bn | 15.45 Bn | 362.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5,434.00 |
| Mar 31, 2026 | 417.00 |
| Dec 31, 2025 | 132.00 |
| Sep 30, 2025 | 3,865.00 |
| Jun 30, 2025 | 6,780.00 |
| Mar 31, 2025 | -10,435.00 |
| Dec 31, 2024 | 17,033.00 |
| Sep 30, 2024 | 20,290.00 |
| Jun 30, 2024 | -31,893.00 |
| Mar 31, 2024 | -2,776.00 |
| Dec 31, 2023 | 25,633.00 |
| Sep 30, 2023 | 1,735.00 |
| Jun 30, 2023 | 13,060.00 |
| Mar 31, 2023 | 13,948.00 |
| Dec 31, 2022 | 37,784.00 |
| Sep 30, 2022 | 135,836.00 |
| Jun 30, 2022 | -42,840.00 |
| Mar 31, 2022 | -176,170.00 |
| Dec 31, 2021 | 859,572.00 |
| Sep 30, 2021 | 280,061.00 |